Just Biotherapeutics donations received
This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
Table of contents
Basic donee information
Donation amounts by donor and year for donee Just Biotherapeutics
|Bill and Melinda Gates Foundation (filter this donee)
Full list of donations in reverse chronological order (3 donations)
|Donor||Amount (current USD)||Donation date||Cause area||URL||Influencer||Notes|
|Bill and Melinda Gates Foundation||4,546,022.00||2017-11-17||Global health/infectious disease control||https://iatiregistry.org/publisher/bmgf||-- ||to provide sequence/structure assessment and optimization of 3 candidate monoclonal antibodies, and process development and GMP manufacturing of 2 of the 3 optimized candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
|Bill and Melinda Gates Foundation||9,499,824.00||2015-10-16||Global health/STD control including HIV/AIDS||https://iatiregistry.org/publisher/bmgf||-- ||to develop sequence optimized anti-HIV molecules that will be significantly less expensive to manufacture and have improved stability allowing for easier distribution outside of the cold chain in low and middle income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
|Bill and Melinda Gates Foundation||14,998,577.00||2015-07-29||Global health/infectious disease control||https://iatiregistry.org/publisher/bmgf||-- ||to develop novel technologies to lower the commercial cost of monoclonal antibodies (mAbs) for infectious diseases in low income markets; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.